1. Home
  2. VKTX vs HSAI Comparison

VKTX vs HSAI Comparison

Compare VKTX & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • HSAI
  • Stock Information
  • Founded
  • VKTX 2012
  • HSAI 2014
  • Country
  • VKTX United States
  • HSAI China
  • Employees
  • VKTX N/A
  • HSAI N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • HSAI
  • Sector
  • VKTX Health Care
  • HSAI
  • Exchange
  • VKTX Nasdaq
  • HSAI Nasdaq
  • Market Cap
  • VKTX 3.5B
  • HSAI 2.8B
  • IPO Year
  • VKTX 2015
  • HSAI 2023
  • Fundamental
  • Price
  • VKTX $34.42
  • HSAI $21.30
  • Analyst Decision
  • VKTX Strong Buy
  • HSAI Strong Buy
  • Analyst Count
  • VKTX 13
  • HSAI 1
  • Target Price
  • VKTX $86.92
  • HSAI $29.30
  • AVG Volume (30 Days)
  • VKTX 4.1M
  • HSAI 3.0M
  • Earning Date
  • VKTX 07-23-2025
  • HSAI 08-18-2025
  • Dividend Yield
  • VKTX N/A
  • HSAI N/A
  • EPS Growth
  • VKTX N/A
  • HSAI N/A
  • EPS
  • VKTX N/A
  • HSAI N/A
  • Revenue
  • VKTX N/A
  • HSAI $309,148,901.00
  • Revenue This Year
  • VKTX N/A
  • HSAI $61.71
  • Revenue Next Year
  • VKTX N/A
  • HSAI $43.70
  • P/E Ratio
  • VKTX N/A
  • HSAI N/A
  • Revenue Growth
  • VKTX N/A
  • HSAI 24.20
  • 52 Week Low
  • VKTX $18.92
  • HSAI $3.52
  • 52 Week High
  • VKTX $81.73
  • HSAI $24.65
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 73.08
  • HSAI 50.21
  • Support Level
  • VKTX $31.22
  • HSAI $20.45
  • Resistance Level
  • VKTX $33.61
  • HSAI $21.88
  • Average True Range (ATR)
  • VKTX 1.77
  • HSAI 1.40
  • MACD
  • VKTX 0.32
  • HSAI -0.24
  • Stochastic Oscillator
  • VKTX 89.49
  • HSAI 27.99

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: